<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Ventilation Heterogeneity in Ex-smokers without Airflow Limitation" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/ventilation-heterogeneity-in-ex-smokers-without-airflow-limitation/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/ventilation-heterogeneity-in-ex-smokers-without-airflow-limitation/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2015-07-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Ventilation Heterogeneity in Ex-smokers without Airflow Limitation" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T03:59:08+00:00","datePublished":"2015-07-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Ventilation Heterogeneity in Ex-smokers without Airflow Limitation","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/ventilation-heterogeneity-in-ex-smokers-without-airflow-limitation/"},"url":"https://clinicaltree.github.io/posts/ventilation-heterogeneity-in-ex-smokers-without-airflow-limitation/"}</script><title>Ventilation Heterogeneity in Ex-smokers without Airflow Limitation | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Ventilation Heterogeneity in Ex-smokers without Airflow Limitation</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Ventilation Heterogeneity in Ex-smokers without Airflow Limitation</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1438362000" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Jul 31, 2015 </em> </span> <span> Updated <em class="" data-ts="1681099148" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Damien Pike BSc</a> </em>, <em> <a href="">Mira Kirby PhD</a> </em>, <em> <a href="">Fumin Guo MEng</a> </em>, <em> <a href="">David G. McCormack MD FRCPC</a> </em>, <em> <a href="">Grace Parraga PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="2876 words"> <em>15 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Hyperpolarized 3 He magnetic resonance imaging (MRI) ventilation abnormalities are visible in ex-smokers without airflow limitation, but the clinical relevance of this is not well-understood. Our objective was to phenotype healthy ex-smokers with normal and abnormally elevated ventilation defect percent (VDP).</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Sixty ex-smokers without airflow limitation provided written informed consent to 3 He MRI, computed tomography (CT), and pulmonary function tests in a single visit. 3 He MRI VDP and apparent diffusion coefficients (ADCs) were measured for whole-lung and each lung lobe as were CT measurements of emphysema (relative area [RA] with attenuation ≤−950 HU, RA 950 ) and airway morphology (wall area percent [WA%], lumen area [LA] and LA normalized to body surface area [LA/BSA]).</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>In 42 ex-smokers, there was abnormally elevated VDP and no significant differences for pulmonary function, RA 950 , or airway measurements compared to 18 ex-smokers with normal VDP. Ex-smokers with abnormally elevated VDP reported significantly greater 3 He ADC in the apical lung (right upper lobe [RUL], <em>P</em> = .02; right middle lobe [RML], <em>P</em> = .04; and left upper lobe [LUL], <em>P</em> = .009). Whole lung (r = 0.40, <em>P</em> = .001) and lobar VDP (RUL, r = 0.32, <em>P</em> = .01; RML, r = 0.46, <em>P</em> = .002; right lower lobe [RLL], r = 0.38, <em>P</em> = .003; LUL, r = 0.35, <em>P</em> = .006; and left lower lobe, r = 0.37, <em>P</em> = .004) correlated with regional 3 He ADC. Although whole-lung VDP and CT airway morphology measurements were not correlated, regional VDP was correlated with RUL LA (r = −0.37, <em>P</em> = .004), LA/BSA (r = −0.42, <em>P</em> = .0008), RLL WA% (r = 0.28, <em>P</em> = .03), LA (r = −0.28, <em>P</em> = .03), and LA/BSA (r = −0.37, <em>P</em> = .004).</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Abnormally elevated VDP in ex-smokers without airflow limitation was coincident with very mild emphysema detected using MRI and regional airway remodeling detected using CT representing a subclinical obstructive lung disease phenotype.</p><p>Chronic obstructive pulmonary disease (COPD) is characterized by irreversible airflow limitation caused by small airway remodeling, airway obliteration , and emphysematous tissue destruction . COPD is typically diagnosed after respiratory symptoms become obvious and intolerable , and this usually occurs when spirometry measurements of lung function reflect airflow limitation and obstruction. However, it is well understood that ex- and current-smokers may report normal lung function and mild symptoms, and this may represent an early or “subclinical” phase. A deep understanding of the underlying morphologic changes that accompany this “subclinical” phase is lacking, mainly because methods for evaluating pulmonary function cannot detect very mild or early structure–function abnormalities.</p><p>Hyperpolarized 3 He magnetic resonance imaging (MRI) ventilation heterogeneity has been shown in patients with pulmonary diseases such as COPD , asthma , and cystic fibrosis . At the same time, however, preclinical or subclinical 3 He ventilation heterogeneity has also been observed in volunteers without clinical signs or symptoms of lung disease such as healthy elderly never-smokers , ex-smokers without airflow limitation , in second-hand smoke exposed adults , and current-smokers without disease . To evaluate the underlying anatomic and structural determinants of ventilation heterogeneity, thoracic x-ray computed tomography (CT) has been used to help determine the spatial relationship of airways disease and emphysema with ventilation abnormalities. For example, recent work provided evidence that in COPD, 3 He ventilation defects represent regions of emphysema and airways disease and that this relationship depends on disease severity. In asthma , 3 He ventilation heterogeneity was also shown to be spatially related to abnormally remodeled airways. However, the pathophysiological origins and contributions of very mild or subclinical airways disease and emphysema to ventilation heterogeneity in ex-smokers without airflow limitation have not been investigated and remain poorly understood.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="study-participants"><span class="mr-2">Study Participants</span><a href="#study-participants" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="spirometry-and-plethysmography"><span class="mr-2">Spirometry and Plethysmography</span><a href="#spirometry-and-plethysmography" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="imaging"><span class="mr-2">Imaging</span><a href="#imaging" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="image-analysis"><span class="mr-2">Image Analysis</span><a href="#image-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>95%CL=x¯+1.96·σn√ 95</p><p>%</p><p>CL</p><p>=</p><p>x</p><p>¯</p><p>+</p><p>1.96</p><p>·</p><p>σ</p><p>n</p><p>where x¯ x</p><p>¯ is the mean VDP of the 51 healthy never-smokers, σ σ is the standard deviation of VDP of the 51 healthy never-smokers, and <em>n</em> is the total number of healthy never-smokers. The upper limit of normal (95% CI) for VDP was calculated to be 4.3%. Therefore, ex-smokers with VDP &lt;4.3% were classified as normal, whereas ex-smokers with VDP ≥4.3% were classified as having abnormally elevated VDP.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistics"><span class="mr-2">Statistics</span><a href="#statistics" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Demographic, Pulmonary Function, and Imaging Data</p><p>Parameter (±SD) All <em>n</em> = 60 Normal VDP ( <em>n</em> = 18) Elevated VDP ( <em>n</em> = 42)<em>P</em> Value ∗ Age, y 69 (9) 67 (10) 70 (9) .23 (1.0) Male, <em>n</em> (%) 38 (63) 9 (50) 29 (69) .17 (1.0) Pack years 28 (16) 27 (14) 28 (17) .86 (1.0) Years quit smoking 19 (15) 13 (12) 21 (15) .06 (1.0) BMI, kg/m 2 29 (4) 29 (5) 30 (4) .5 (1.0) FVC, % pred 97 (13) 100 (10) 95 (14) .18 (1.0) FEV 1 , % pred 104 (13) 106 (12) 102 (14) .28 (1.0) FEV 1 /FVC 80 (6) 80 (6) 80 (6) .78 (1.0) RV/TLC, % pred 103 (15) 104 (12) 103 (16) .76 (1.0) DL CO , % pred 80 (20) 87 (16) 77 (22) .11 (1.0) 6MWD, m 404 (95) 433 (81) 392 (98) .12 (1.0) SGRQ total 36 (26) 22 (20) 23 (22) .78 (1.0) WA % 65 (2) 65 (2) 65 (2) .89 (0.89) LA, mm 2 14 (3) 13 (2) 14 (4) .36 (1.0) LA/BSA, mm 2 /m 2 7 (2) 7 (1) 7 (2) .81 (1.0) Airway count 115 (37) 106 (28) 119 (40) .20 (1.0) RA 950 , % 1.2 (1.0) 0.8 (0.5) 1.4 (1.1) .08 (1.0) VDP, % 6 (3) 3 (1) 7 (3) &lt;.0001 (&lt;.0001) ADC, cm 2 /s 0.28 (0.04) 0.26 (0.03) 0.29 (0.03) .01 (.18)</p><p>ADC, apparent diffusion coefficient; BMI, body mass index; BSA, body surface area; DL CO , diffusing capacity for carbon monoxide; FEV 1 , forced expiratory volume in 1 second; FVC, forced vital capacity; LA, mean fifth generation airway lumen area; 6MWD, six-minute walk distance; RA 950 , relative area of the lung parenchyma with attenuation ≤−950 HU; RV, residual volume; SD, standard deviation; SGRQ, St. Georges Respiratory Questionnaire; TLC, total lung capacity; VDP, ventilation defect percent; WA%, mean fifth generation airway wall area percent.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VentilationHeterogeneityinExsmokerswithoutAirflowLimitation/0_1s20S1076633215001907.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VentilationHeterogeneityinExsmokerswithoutAirflowLimitation/0_1s20S1076633215001907.jpg" alt="Figure 1, 3 He magnetic resonance imaging ventilation and computed tomography airway trees in representative ex-smokers with normal (S1–S3) and abnormally elevated ventilation defect percent (VDP) (S4–S6) (airway measurements displayed as wall area percent and lumen area [mm 2 ]) S1 = 70-year-old woman, 12 pack years, forced expiratory volume in 1 second (FEV1) = 93% and VDP = 2%; S2 = 59-year-old woman, 18 pack years, FEV1 = 97% and VDP = 2%; S3 = 51–year-old woman, 20 pack years, FEV1 = 103% and VDP = 4%; S4 = 74–year-old man, 50 pack years, FEV1 = 89% and VDP = 8%; S5 = 79–year-old man, 10 pack years, FEV1 = 88% and VDP = 11%; and S6 = 74–year-old man, 60 pack years, FEV1 = 95% and VDP = 6%." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 2</p><p>Whole Lung and Regional Measurements for Ex-smokers with Normal and Elevated VDP</p><p>Parameter (±SD) Normal VDP (n = 18) Elevated VDP (n = 42)<em>P</em> Value Whole lung WA% ∗ 65 (2) 65 (2) .88 LA, mm 2 ∗ 13 (2) 14 (4) .50 LA/BSA, mm 2 /m 2 ∗ 7 (1) 7 (2) .57 VDP, % 3 (1) 7 (3) &lt;.0001 ADC, cm 2 /s 0.26 (0.03) 0.29 (0.03) .01 RA 950 , % 0.8 (0.5) 1.4 (1.1) .08 Right upper lobe RB1 WA% 62 (2) 61 (4) .29 RB1 LA, mm 2 25 (5) 25 (11) .64 RB1 LA/BSA, mm 2 /m 2 13 (3) 13 (6) .39 VDP, % 3 (2) 5 (4) .02 ADC, cm 2 /s 0.24 (0.03) 0.27 (0.03) .02 RA 950 , % 0.7 (0.6) 1.2 (1.2) .08 Right middle lobe RB5 WA% 63 (4) 62 (4) .25 RB5 LA, mm 2 22 (13) 21 (8) .80 RB5 LA/BSA, mm 2 /m 2 12 (7) 11 (4) .99 VDP, % 6 (9) 9 (10) .04 ADC, cm 2 /s 0.24 (0.03) 0.27 (0.04) .04 RA 950 , % 1.6 (1.0) 2.0 (1.8) .79 Right lower lobe RB8 WA% 62 (3) 62 (3) .43 RB8 LA, mm 2 21 (8) 21 (7) .99 RB8 LA/BSA, mm 2 /m 2 11 (5) 11 (4) .67 VDP, % 5 (3) 8 (6) .02 ADC, cm 2 /s 0.25 (0.03) 0.27 (0.03) .07 RA 950 , % 0.6 (0.4) 1.0 (1.0) .42 Left upper lobe LB1 WA% 63 (3) 63 (3) .52 LB1 LA, mm 2 15 (4) 18 (6) .19 LB1 LA/BSA, mm 2 /m 2 8 (2) 9 (3) .34 VDP, % 4 (4) 8 (8) .02 ADC, cm 2 /s 0.25 (0.03) 0.28 (0.04) .009 RA 950 , % 1.0 (0.6) 1.8 (1.7) .22 Left lower lobe LB8 WA% 59 (4) 60 (4) .68 LB8 LA, mm 2 30 (11) 28 (12) .27 LB8 LA/BSA, mm 2 /m 2 17 (8) 14 (6) .13 VDP, % 3 (1) 7 (3) &lt;.0001 ADC, cm 2 /s 0.25 (0.03) 0.27 (0.04) .07 RA 950 , % 0.7 (0.4) 1.1 (1.1) .42</p><p>ADC, 3 He magnetic resonance imaging apparent diffusion coefficient; BSA, body surface area; LA, lumen area; LB1, left upper lobe apical bronchus; LB8, left lower lobe subsegmental bronchus; RA 950 , relative area of the lung parenchyma with attenuation ≤−950 HU; RB1, right upper lobe apical bronchus; RB5, right middle lobe lateral bronchus; RB8, right lower lobe subsegmental bronchus; SD, standard deviation; VDP, 3 He magnetic resonance imaging ventilation defect percent; WA%, wall area percent.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VentilationHeterogeneityinExsmokerswithoutAirflowLimitation/1_1s20S1076633215001907.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VentilationHeterogeneityinExsmokerswithoutAirflowLimitation/1_1s20S1076633215001907.jpg" alt="Figure 2, Whole lung (WL) and regional emphysema measurements in ex-smokers with normal ( n = 18) and abnormally elevated ventilation defect percent (VDP; n = 42; Holm–Bonferroni corrected P Values in parentheses). ADC was significantly greater in apical lung in subjects with elevated VDP. After correcting for multiple comparisons, only the comparison of LUL ADC remained on the threshold of significance. (a) Whole lung ADC ( P = .02, corrected 0.08), (b) right upper lobe ADC ( P = .02, corrected 0.1), (c) left upper lobe ADC ( P = .009, corrected 0.05), (d) right middle lobe ADC ( P = .04, corrected 0.12), (e) left lower lobe ADC ( P = .07, corrected 0.07), and (f) right lower lobe ADC ( P = .07, corrected 0.10). ADC, apparent diffusion coefficient; LLL, left lower lobe; LUL, left upper lobe; RLL, right lower lobe; RML, right middle lobe; RUL, right upper lobe." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 3</p><p>Relationship of 3 He MRI VDP with Airways Disease and Emphysema Measurements</p><p>Parameter Spearman <em>r__P</em> Value Whole lung VDP WA% ∗ 0.002 .99 LA ∗ 0.04 .76 LA/BSA ∗ −0.04 .75 ADC 0.40 .001 RA 950 0.34 .008 Right upper lobe VDP RB1 WA% 0.24 .06 RB1 LA −0.37 .004 RB1 LA/BSA −0.42 .0008 ADC 0.32 .01 RA 950 0.15 .27 Right middle lobe VDP RB5 WA% −0.11 .40 RB5 LA −0.003 .98 RB5 LA/BSA −0.02 .91 ADC 0.46 .002 RA 950 0.24 .07 Right lower lobe VDP RB8 WA% 0.28 .03 RB8 LA −0.28 .03 RB8 LA/BSA −0.37 .004 ADC 0.38 .003 RA 950 0.21 .11 Left upper lobe VDP LB1 WA% 0.07 .62 LB1 LA 0.13 .33 LB1 LA/BSA −0.01 .94 ADC 0.35 .006 RA 950 0.23 .08 Left lower lobe VDP LB8 WA% 0.04 .73 LB8 LA 0.05 .68 LB8 LA/BSA −0.02 .86 ADC 0.37 .004 RA 950 0.26 .05</p><p>ADC, 3 He MRI apparent diffusion coefficient; BSA, body surface area; LA, lumen area; LB1, left upper lobe apical bronchus; LB8, left lower lobe subsegmental bronchus; MRI, magnetic resonance imaging; RA 950 , relative area of the lung parenchyma with attenuation ≤−950 HU; RB1, right upper lobe apical bronchus; RB5, right middle lobe lateral bronchus; RB8, right lower lobe subsegmental bronchus; VDP, 3 He MRI ventilation defect percent; WA%, wall area percent.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VentilationHeterogeneityinExsmokerswithoutAirflowLimitation/2_1s20S1076633215001907.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VentilationHeterogeneityinExsmokerswithoutAirflowLimitation/2_1s20S1076633215001907.jpg" alt="Figure 3, Relationships for whole lung and regional ventilation defect percent (VDP) with 3 He magnetic resonance imaging emphysema measurements. (a) Whole lung (WL) VDP correlated with WL ADC (r = 0.40, P = .001), (b) RUL VDP correlated with RUL ADC (r = 0.32, P = .01), (c) RLL VDP correlated with RLL ADC (r = 0.38, P = .003), (d) RML VDP correlated with RML ADC (r = 0.46, P = .002), (e) LUL VDP correlated with LUL ADC (r = 0.35, P = .006), and (f) LLL VDP correlated with LLL ADC (r = 0.37, P = .004). ADC, apparent diffusion coefficient; LLL, left lower lobe; LUL, left upper lobe; RLL, right lower lobe; RML, right middle lobe; RUL, right upper lobe." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VentilationHeterogeneityinExsmokerswithoutAirflowLimitation/3_1s20S1076633215001907.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/VentilationHeterogeneityinExsmokerswithoutAirflowLimitation/3_1s20S1076633215001907.jpg" alt="Figure 4, Relationships for regional ventilation defect percent (VDP) with computed tomography airways disease measurements. Right upper lobe (RUL) VDP correlated with (a) RB1 lumen area (LA) (r = −0.37, P = .004), (b) RB1 LA/body surface area (BSA) (r = −0.42, P = .0008) but not (c) RB1 wall area percent (WA%) (r = 0.24, P = .06). Right lower lobe (RLL) VDP correlated with (d) RB8 LA (r = −0.28, P = .03), (e) RB8 LA/BSA (r = −0.37, P = .004), and (f) RB8 WA% (r = 0.28, P = .03)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="acknowledgments"><span class="mr-2">Acknowledgments</span><a href="#acknowledgments" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="supplementary-data"><span class="mr-2">Supplementary data</span><a href="#supplementary-data" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Supplemental Table 1</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Hogg J.C., Chu F., Utokaparch S., et. al.: The nature of small-airway obstruction in chronic obstructive pulmonary disease. The New England journal of medicine 2004; 350: pp. 2645-2653.</p><li><p>2. McDonough J.E., Yuan R., Suzuki M., et. al.: Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. The New England journal of medicine 2011; 365: pp. 1567-1575.</p><li><p>3. Vestbo J., Hurd S.S., Agusti A.G., et. al.: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American journal of respiratory and critical care medicine 2013; 187: pp. 347-365.</p><li><p>4. van Beek E.J., Dahmen A.M., Stavngaard T., et. al.: Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial. The European respiratory journal 2009; 34: pp. 1311-1321.</p><li><p>5. Kirby M., Mathew L., Heydarian M., et. al.: Chronic obstructive pulmonary disease: quantification of bronchodilator effects by using hyperpolarized (3)He MR imaging. Radiology 2011; 261: pp. 283-292.</p><li><p>6. Fain S.B., Gonzalez-Fernandez G., Peterson E.T., et. al.: Evaluation of structure-function relationships in asthma using multidetector CT and hyperpolarized He-3 MRI. Academic radiology 2008; 15: pp. 753-762.</p><li><p>7. Svenningsen S., Kirby M., Starr D., et. al.: What are ventilation defects in asthma?. Thorax 2014; 69: pp. 63-71.</p><li><p>8. Mentore K., Froh D.K., de Lange E.E., et. al.: Hyperpolarized HHe 3 MRI of the lung in cystic fibrosis: assessment at baseline and after bronchodilator and airway clearance treatment 1 . Academic radiology 2005; 12: pp. 1423-1429.</p><li><p>9. Sheikh K., Paulin G.A., Svenningsen S., et. al.: Pulmonary ventilation defects in older never-smokers. J Appl Physiol (1985) 2014; 117: pp. 297-306.</p><li><p>10. Woodhouse N., Wild J.M., Paley M.N., et. al.: Combined helium-3/proton magnetic resonance imaging measurement of ventilated lung volumes in smokers compared to never-smokers. Journal of magnetic resonance imaging : JMRI 2005; 21: pp. 365-369.</p><li><p>11. Wang C., Mugler J.P., de Lange E.E., et. al.: Lung injury induced by secondhand smoke exposure detected with hyperpolarized helium-3 diffusion MR. Journal of magnetic resonance imaging : JMRI 2014; 39: pp. 77-84.</p><li><p>12. Fain S.B., Panth S.R., Evans M.D., et. al.: Early emphysematous changes in asymptomatic smokers: detection with 3He MR imaging. Radiology 2006; 239: pp. 875-883.</p><li><p>13. Kirby M., Pike D., Coxson H.O., et. al.: Hyperpolarized 3He ventilation defects used to predict pulmonary exacerbations in mild to moderate chronic obstructive pulmonary disease. Radiology 2014; pp. 140161.</p><li><p>14. Miller M.R., Hankinson J., Brusasco V., et. al.: Standardisation of spirometry. The European respiratory journal 2005; 26: pp. 319-338.</p><li><p>15. Kirby M., Heydarian M., Svenningsen S., et. al.: Hyperpolarized 3He magnetic resonance functional imaging semiautomated segmentation. Academic radiology 2012; 19: pp. 141-152.</p><li><p>16. Kirby M., Heydarian M., Wheatley A., et. al.: Evaluating bronchodilator effects in chronic obstructive pulmonary disease using diffusion-weighted hyperpolarized helium-3 magnetic resonance imaging. Journal of applied physiology 2012; 112: pp. 651-657.</p><li><p>17. Niimi A., Matsumoto H., Amitani R., et. al.: Airway wall thickness in asthma assessed by computed tomography: relation to clinical indices. American journal of respiratory and critical care medicine 2000; 162: pp. 1518-1523.</p><li><p>18. West J.B.: Respiratory physiology: the essentials.8th ed.2008.Lippincott Williams and Wilkins</p><li><p>19. Wan E.S., Hokanson J.E., Murphy J.R., et. al.: Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. American journal of respiratory and critical care medicine 2011; 184: pp. 57-63.</p><li><p>20. Coxson H.O., Dirksen A., Edwards L.D., et. al.: The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study. The lancet Respiratory medicine 2013; 1: pp. 129-136.</p><li><p>21. Yablonskiy D.A., Sukstanskii A.L., Woods J.C., et. al.: Quantification of lung microstructure with hyperpolarized 3He diffusion MRI. Journal of applied physiology 2009; 107: pp. 1258-1265.</p><li><p>22. Evans A., McCormack D., Ouriadov A., et. al.: Anatomical distribution of 3He apparent diffusion coefficients in severe chronic obstructive pulmonary disease. Journal of magnetic resonance imaging : JMRI 2007; 26: pp. 1537-1547.</p><li><p>23. Miller R.R., Muller N.L., Vedal S., et. al.: Limitations of computed tomography in the assessment of emphysema. The American review of respiratory disease 1989; 139: pp. 980-983.</p><li><p>24. Coxson H.O., Leipsic J., Parraga G., et. al.: Using pulmonary imaging to move chronic obstructive pulmonary disease beyond FEV1. American journal of respiratory and critical care medicine 2014; 190: pp. 135-144.</p><li><p>25. Yahaba M., Kawata N., Iesato K., et. al.: The effects of emphysema on airway disease: correlations between multi-detector CT and pulmonary function tests in smokers. European journal of radiology 2014; 83: pp. 1022-1028.</p><li><p>26. Nakano Y., Muro S., Sakai H., et. al.: Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. American journal of respiratory and critical care medicine 2000; 162: pp. 1102-1108.</p><li><p>27. Coxson H.O.: Quantitative chest tomography in COPD research: chairman’s summary. Proceedings of the American Thoracic Society 2008; 5: pp. 874-877.</p><li><p>28. Coxson H.O.: Quantitative computed tomography assessment of airway wall dimensions: current status and potential applications for phenotyping chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 2008; 5: pp. 940-945.</p><li><p>29. Swift A.J., Wild J.M., Fichele S., et. al.: Emphysematous changes and normal variation in smokers and COPD patients using diffusion 3He MRI. European journal of radiology 2005; 54: pp. 352-358.</p><li><p>30. Fain S.B., Altes T.A., Panth S.R., et. al.: Detection of age-dependent changes in healthy adult lungs with diffusion-weighted 3He MRI. Academic radiology 2005; 12: pp. 1385-1393.</p><li><p>31. Galban C.J., Han M.K., Boes J.L., et. al.: Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nature medicine 2012; 18: pp. 1711-1715.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-22/'>Volume 22</a>, <a href='/categories/issue-8/'>Issue 8</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Ventilation%20Heterogeneity%20in%20Ex-smokers%20without%20Airflow%20Limitation%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fventilation-heterogeneity-in-ex-smokers-without-airflow-limitation%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Ventilation%20Heterogeneity%20in%20Ex-smokers%20without%20Airflow%20Limitation%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fventilation-heterogeneity-in-ex-smokers-without-airflow-limitation%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fventilation-heterogeneity-in-ex-smokers-without-airflow-limitation%2F&text=Ventilation%20Heterogeneity%20in%20Ex-smokers%20without%20Airflow%20Limitation%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/adherence-to-thresholds/"><div class="card-body"> <em class="small" data-ts="1438362000" data-df="ll" > Jul 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Adherence to Thresholds</h3><div class="text-muted small"><p> Thresholds derived from quantification in imaging are increasingly used to define disease. This derivation is not an exact science. When one uses a threshold to define a disease, one does not clear...</p></div></div></a></div><div class="card"> <a href="/posts/an-overview-of-methodologies-in-detecting-overdiagnosis/"><div class="card-body"> <em class="small" data-ts="1438362000" data-df="ll" > Jul 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>An Overview of Methodologies in Detecting Overdiagnosis</h3><div class="text-muted small"><p> Owing to imperfect information, overdiagnosis cannot be predicted with certainty before the fact . Overdiagnosis is inferred . The fact that overdiagnosis is inferred places unique challenges on th...</p></div></div></a></div><div class="card"> <a href="/posts/analysis-of-statistical-biases-in-studies-used-to-formulate-guidelines/"><div class="card-body"> <em class="small" data-ts="1438362000" data-df="ll" > Jul 31, 2015 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Analysis of Statistical Biases in Studies Used to Formulate Guidelines</h3><div class="text-muted small"><p> Rationale and Objectives To analyze the statistical biases in the studies used to derive cardiac magnetic resonance–based major and minor criteria for the diagnosis of arrhythmogenic right ventric...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/utilization-and-reporting-of-bone-densitometry/" class="btn btn-outline-primary" prompt="Older"><p>Utilization and Reporting of Bone Densitometry</p></a> <a href="/posts/will-pet-amyloid-imaging-lead-to-overdiagnosis-of-alzheimer-dementia/" class="btn btn-outline-primary" prompt="Newer"><p>Will PET Amyloid Imaging Lead to Overdiagnosis of Alzheimer Dementia?</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
